RPG Life Sciences Limited (BOM:532983)
India
· Delayed Price · Currency is INR 2,064.10
+92.55 (4.69%)
At close: Apr 11, 2025
RPG Life Sciences Statistics
Total Valuation
BOM:532983 has a market cap or net worth of INR 38.59 billion. The enterprise value is 37.33 billion.
| Market Cap | 38.59B |
| Enterprise Value | 37.33B |
Important Dates
The next estimated earnings date is Monday, April 28, 2025.
| Earnings Date | Apr 28, 2025 |
| Ex-Dividend Date | Jun 28, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 4.29M |
Valuation Ratios
The trailing PE ratio is 48.77.
| PE Ratio | 48.77 |
| Forward PE | n/a |
| PS Ratio | 6.06 |
| PB Ratio | 10.17 |
| P/TBV Ratio | 10.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 47.18 |
| EV / Sales | 5.86 |
| EV / EBITDA | 24.54 |
| EV / EBIT | 27.79 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 231.60 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 23.48% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 5.02M |
| Profits Per Employee | 623,071 |
| Employee Count | 1,270 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +35.44% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +35.44% |
| 50-Day Moving Average | 2,228.20 |
| 200-Day Moving Average | 2,215.65 |
| Relative Strength Index (RSI) | 57.11 |
| Average Volume (20 Days) | 1,010 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532983 had revenue of INR 6.37 billion and earned 791.30 million in profits. Earnings per share was 47.84.
| Revenue | 6.37B |
| Gross Profit | 4.26B |
| Operating Income | 1.34B |
| Pretax Income | 1.16B |
| Net Income | 791.30M |
| EBITDA | 1.52B |
| EBIT | 1.34B |
| Earnings Per Share (EPS) | 47.84 |
Balance Sheet
The company has 1.26 billion in cash and n/a in debt, giving a net cash position of 1.26 billion.
| Cash & Cash Equivalents | 1.26B |
| Total Debt | n/a |
| Net Cash | 1.26B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.79B |
| Book Value Per Share | 229.43 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 66.82%, with operating and profit margins of 21.08% and 12.42%.
| Gross Margin | 66.82% |
| Operating Margin | 21.08% |
| Pretax Margin | 18.16% |
| Profit Margin | 12.42% |
| EBITDA Margin | 23.80% |
| EBIT Margin | 21.08% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 16.00, which amounts to a dividend yield of 0.78%.
| Dividend Per Share | 16.00 |
| Dividend Yield | 0.78% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 5 |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | 0.77% |
| Earnings Yield | 2.05% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |